CSRT.L : Summary for CONSORT MEDICAL PLC ORD 10P - Yahoo Finance

U.S. Markets closed

Consort Medical plc (CSRT.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
1,009.00+4.00 (+0.40%)
At close: 4:35PM GMT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1,005.00
Open1,010.00
Bid0.00 x 75800
Ask0.00 x 38000
Day's Range987.00 - 1,010.00
52 Week Range940.00 - 1,180.00
Volume3,538
Avg. Volume114,947
Market Cap493.47M
BetaN/A
PE Ratio (TTM)26.34
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Consort Medical Plc : Undervalued relative to peers, but don’t ignore the other factors
    Capital Cube5 days ago

    Consort Medical Plc : Undervalued relative to peers, but don’t ignore the other factors

    Categories: Yahoo Finance Consort Medical Plc relative valuation is now UNDERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 63. Our analysis is based on comparing Consort Medical Plc with the following peers – Surgical Innovations Group plc, Animalcare Group plc, AstraZeneca PLC and GlaxoSmithKline plc (SUN-GB, ANCR-GB, AZN-GB and GSK-GB). Relative Valuation Consort ... Read more (Read more...)

  • The Wall Street Journal2 months ago

    [$$] British American Tobacco Ends Sole Supply Deal for Nicotine Inhaler

    BAT terminated the supplier agreement for its long-delayed Voke nicotine inhaler, which the tobacco giant had promoted as setting it apart in the market for cigarette alternatives.

  • Consort Medical Plc :CSRT-GB: Earnings Analysis: For the six months ended October 31, 2016 : December 12, 2016
    Capital Cube2 months ago

    Consort Medical Plc :CSRT-GB: Earnings Analysis: For the six months ended October 31, 2016 : December 12, 2016

    Categories: Yahoo Finance Get free summary analysis Consort Medical Plc reports financial results for the half-year ended October 31, 2016. We analyze the earnings along side the following peers of Consort Medical Plc – AstraZeneca PLC and GlaxoSmithKline plc (AZN-GB and GSK-GB) that have also reported for this period. Highlights Summary numbers: Revenues of GBP 144.93 million, Net ... Read more (Read more...)